000305633 001__ 305633
000305633 005__ 20251109023649.0
000305633 0247_ $$2doi$$a10.1186/s12885-025-14464-7
000305633 0247_ $$2pmid$$apmid:41188772
000305633 0247_ $$2altmetric$$aaltmetric:184086970
000305633 037__ $$aDKFZ-2025-02275
000305633 041__ $$aEnglish
000305633 082__ $$a610
000305633 1001_ $$aPeng, Shixuan$$b0
000305633 245__ $$aAssociation of the American heart association's new 'life's essential 8' cardiovascular health with all-cause and cardiovascular mortality in adults with and without cancer: a retrospective cohort study.
000305633 260__ $$aLondon$$bBioMed Central$$c2025
000305633 3367_ $$2DRIVER$$aarticle
000305633 3367_ $$2DataCite$$aOutput Types/Journal article
000305633 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1762420893_1579197
000305633 3367_ $$2BibTeX$$aARTICLE
000305633 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000305633 3367_ $$00$$2EndNote$$aJournal Article
000305633 520__ $$aThe American Heart Association released an updated algorithm used to assess cardiovascular health (CVH)-the Life's Essential 8 (LE8) score. Our objective was to quantify the association between CVH levels estimated by the LE8 score and all-cause and cardiovascular mortality in adults with and without cancer.In this retrospective cohort study, 29,352 adults were included from the National Health and Nutrition Examination Survey (NHANES) 2005-2018 at baseline linked to the 2019 National Death Index records. Cox regression models and Restricted cubic spline were used to evaluate the associations between CVH with cardiovascular mortality and all-cause mortality.In this study, 14.8% of adults achieved a high total CVH score, compared to 20.3% with low scores. The adjusted HR (95% CI) for all-cause mortality in adults without cancer with a moderate or high CVH total scores compared with low scores was 0.71 (0.64, 0.79) and 0.46 (0.35, 0.60), respectively. The corresponding adjusted HR (95% CI) for cardiovascular disease (CVD) mortality was 0.58 (0.47, 0.72) and 0.30 (0.16, 0.57), respectively. And all 8 CVH indicators in CVD mortality were protective factors. The adjusted HRs (95% CI) for all-cause mortality in adults with cancer with moderate or high scores were 0.73 (0.58, 0.92) and 0.75 (0.48, 1.18), respectively.According to the new LE8, higher CVH scores were associated with a reduced risk of all-cause and CVD-specific mortality in adults with and without cancer.
000305633 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000305633 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000305633 650_7 $$2Other$$aCancer
000305633 650_7 $$2Other$$aCardiovascular health
000305633 650_7 $$2Other$$aLife's essential 8
000305633 650_7 $$2Other$$aMortality
000305633 650_2 $$2MeSH$$aHumans
000305633 650_2 $$2MeSH$$aCardiovascular Diseases: mortality
000305633 650_2 $$2MeSH$$aNeoplasms: mortality
000305633 650_2 $$2MeSH$$aNeoplasms: complications
000305633 650_2 $$2MeSH$$aNeoplasms: epidemiology
000305633 650_2 $$2MeSH$$aFemale
000305633 650_2 $$2MeSH$$aMale
000305633 650_2 $$2MeSH$$aRetrospective Studies
000305633 650_2 $$2MeSH$$aMiddle Aged
000305633 650_2 $$2MeSH$$aAdult
000305633 650_2 $$2MeSH$$aAmerican Heart Association
000305633 650_2 $$2MeSH$$aNutrition Surveys
000305633 650_2 $$2MeSH$$aUnited States: epidemiology
000305633 650_2 $$2MeSH$$aAged
000305633 650_2 $$2MeSH$$aCause of Death
000305633 7001_ $$aChen, Qisheng$$b1
000305633 7001_ $$aLiu, Qianzi$$b2
000305633 7001_ $$0P:(DE-He78)7089188e1b7bdb788ba48ba96f21df07$$aXie, Ruijie$$b3$$udkfz
000305633 7001_ $$aWu, Yongjun$$b4
000305633 773__ $$0PERI:(DE-600)2041352-X$$a10.1186/s12885-025-14464-7$$gVol. 25, no. 1, p. 1706$$n1$$p1706$$tBMC cancer$$v25$$x1471-2407$$y2025
000305633 909CO $$ooai:inrepo02.dkfz.de:305633$$pVDB
000305633 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7089188e1b7bdb788ba48ba96f21df07$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000305633 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000305633 9141_ $$y2025
000305633 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-20
000305633 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-20
000305633 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:34:06Z
000305633 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:34:06Z
000305633 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Open peer review$$d2024-04-10T15:34:06Z
000305633 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-20
000305633 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-20
000305633 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-20
000305633 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-20
000305633 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-20
000305633 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-20
000305633 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-20
000305633 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-20
000305633 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-20
000305633 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie der Krebsfrüherkennung$$x0
000305633 980__ $$ajournal
000305633 980__ $$aVDB
000305633 980__ $$aI:(DE-He78)C070-20160331
000305633 980__ $$aUNRESTRICTED